Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate

Ketosis Clinical Trial

Official title:

Relationship Among Breath Acetone, Blood Beta-Hydroxybutyrate, and Blood Glucose

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03299543
• Other study ID #: LVL-0717
• Status: Completed
• Start date: September 12, 2017
• Est. completion date: February 28, 2018

Study information

• Verified date: August 2018
• Source: Medamonitor
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Subjects will provide blood and breath samples to evaluate the relationship between breath acetone and two blood-bound species: beta-hydroxybutyrate and glucose. Subjects will be asked to provide breath and blood samples at a baseline visit and second optional visit. The two visits will be spaced approximately 3 hours apart.

Description:

The LEVL device (Medamonitor, Seattle, WA) provides users a method for assessing their own rate of fat metabolism. The LEVL device measures the concentration acetone in breath that the scientific literature has shown to correlate to the rate of fat metabolism.

Typically, the body uses glucose to meet its metabolic energy requirements. If needed, the body can shift from using glucose to using fat. Many different scenarios can cause this shift. Exercise can deplete accessible carbohydrate stores causing the body to use fats for energy production. Dietary changes that cause fat intake to increase and carbohydrate intake to decrease will alter metabolism to efficiently utilize the change in nutrients. In all of these scenarios, the body reduces it utilization of carbohydrates and, thus, shifts to using fats for energy production.

When the body uses fats as an energy substrate, some of these fat molecules are converted by the liver into acetoacetate, a ketone body. By enzymatic action, acetoacetate (AcAc) can be converted into beta-hydroxybutyrate (BOHB). The same enzyme can generate AcAc from BOHB. Additionally, acetoacetate can convert spontaneously into acetone which, due to its small size and highly water solubility, can readily appear in the breath.

Currently, measurement of BOHB in blood is the gold standard for assessing ketone body concentration, also known as ketosis. BOHB measurement requires an invasive finger puncture to obtain blood and a costly (~$5 / test) assay. Because acetone (BrAce) is a sister ketone body to BOHB, breath acetone may be used to assess ketosis and replace the measurement of BOHB. Data in the scientific literature has shown BrAce to correlate with BOHB. Inferring BOHB concentrations from measurement of BrAce using LEVL is less invasive and is potentially less costly.

Reports have suggested that breath acetone is inversely correlated to blood sugar. However, others have suggested no relationship between the two species. If a relationship does exist, measurement of breath acetone could be used as a surrogate measure for blood sugar, a common assay used by individuals with diabetes.

In this study, subjects will provide blood and breath samples evaluate the relationship between breath acetone and two blood-bound species: BOHB and glucose. Subjects may be asked to provide breath and blood samples at two different times (i.e., visits) spaced approximately 3 hours apart. The second visit is not required for participation in the study (i.e., optional).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: February 28, 2018
• Est. primary completion date: February 16, 2018
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Subject must complete the consent process

Exclusion Criteria:

1. Subjects with severe lung disease which would prevent them from providing a breath sample through a large bore tube (e.g., large drinking straw)

2. Subjects with diabetes (Type 1 or Type 2)

3. Subjects who are routinely exposed to paints, paint thinners, gasoline, varnishes, glues, dry cleaning solvents, or industrial cleaning products

4. Daily smoker of cigarettes, e-cigarettes, or marijuana

5. Abstain from alcohol over the prior 24 hours

6. Refrain from consumption of large amounts of garlic

Related Conditions & MeSH terms

• Ketosis

Intervention

Device:
• LEVL (Medamonitor)
Subjects will provide duplicate breath samples to the LEVL device for analysis of breath acetone

Locations

Country	Name	City	State
United States	Medamonitor, LLC	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
Medamonitor

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Breath acetone concentration (ppm) will be compared against blood BOHB concentration (mM). The following methods may be used: summary statistics, plotting, and linear regression.	Both individual and average group measurements will be compared	Through study completion, 4 months
Secondary	Breath acetone concentration (ppm) will be compared against blood glucose concentration (mg/dL). The following methods may be used: summary statistics, plotting, and linear regression.	Both individual and average group measurements will be compared	Through study completion, 4 months
Secondary	Blood glucose concentration (mg/dL) will be compared against blood BOHB concentration (mM). The following methods may be used: summary statistics, plotting, and linear regression.	Both individual and average group measurements will be compared	Through study completion, 4 months